SCHEMBL27948519

SCHEMBL27948519

Nc1cccc(-c2ccccc2)c1C1CCCNC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 1/20 0.52
▸ HTR2C P28335 1/20 0.52
▸ KCNH2 Q12809 1/20 0.52
▸ CHRNB2 P17787 4/20 0.48
▸ CHRNA4 P43681 4/20 0.48
▸ CHEK1 O14757 1/20 0.47
▸ CCNA2 P20248 1/20 0.47
▸ CDK2 P24941 1/20 0.47
▸ CCNA1 P78396 1/20 0.47
▸ HTR3E A5X5Y0 1/20 0.44
▸ HTR3B O95264 1/20 0.44
▸ HTR2B P41595 1/20 0.44
▸ HTR3A P46098 1/20 0.44
▸ TMEM97 Q5BJF2 1/20 0.44
▸ HTR3D Q70Z44 1/20 0.44
▸ HTR3C Q8WXA8 1/20 0.44
▸ IKBKB O14920 2/20 0.42
▸ CHRNB4 P30926 2/20 0.41
▸ CHRNA3 P32297 2/20 0.41
▸ HPGDS O60760 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13724213 0.91 CHRNB2 (0.50) HTR2AHTR2CKCNH2CHRNB2CHRNA4
SCHEMBL13724266 0.82 HTR2A (0.48) HTR2AHTR2CKCNH2CHRNB2CHRNA4
SCHEMBL25044094 0.78 CHRNB2 (0.44) HTR2AHTR2CKCNH2CHRNB2CHRNA4
SCHEMBL6173955 0.73 IKBKB (0.44) HTR2AHTR2CKCNH2IKBKBCHUK
SCHEMBL171390 0.72 CHEK1 (0.57) HTR2AHTR2CKCNH2CHEK1CCNA2
SCHEMBL14320456 0.72 IKBKB (0.44) HTR2ACHEK1CCNA2CDK2CCNA1
SCHEMBL2892542 0.72 CSF1R (0.50) HTR2AHTR2CKCNH2CHRNB2CHRNA4
SCHEMBL3399446 0.72 KCNH2 (0.55) HTR2AHTR2CKCNH2HTR3AHPGDS
SCHEMBL21425192 0.71 DRD2 (0.60) HTR2AHTR2CKCNH2CHEK1CCNA2
SCHEMBL22555632 0.71 USP30 (0.51) CHRNB2CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103492389-A Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors ORIGENIS GMBH 2014-01-01 — — CN disclosed
Send feedback